As the conflict in the Middle East disrupts fuel, shipping and food supplies, many are starting to ask if they will be still be able to get their medicines if the war drags on.

Australia’s medicine supply chain is built to handle short disruptions. So you shouldn’t have problems accessing most common medicines in the short to medium term.

But it isn’t designed for prolonged global instability.

What’s in place to protect our medicine supply?

Since July 2023, Australia has had specific stock-holding requirements for many medicines the government subsidises on the Pharmaceutical Benefits Scheme (PBS).

It means manufacturers must hold at least four or six month’ worth of stock of these medicines, depending on the particular medicine, on Australian soil.

This creates a buffer. If a shortage begins, it gives the Therapeutic Goods Administration (TGA), our national medicines regulator, time to respond and reduce the impact.

These medicines aren’t stored in a single warehouse. They’re spread across wholesalers and pharmacies. This helps ensure access across the country, including in regional areas.

The list of medicines covered is reviewed regularly and another review is due this month. This means regulators can adjust which medicines are prioritised as global conditions change.

However, this protection does not apply to every medicine.

If a medicine is not listed on the PBS, the risk of shortages increases. This includes newer medicines and those only available on private........

© The Conversation